[ad_1]
People with a significant history of allergies should not currently receive the Covid-19 vaccine Pfizer Inc. and BioNTech SE, the UK’s National Health Service, said, after two people felt reactions to the gunfire.
Wednesday’s warning came a day after the UK became thewestern first nationto begin a Covid vaccination program, after the vaccine was approved last week by the Medicines and Health Products Regulatory Agency.
“As is often the case with new vaccines, the MHRA has advised as a precaution that people with a significant history of allergic reactions do not receive this vaccination,” said Stephen Powis, national medical director of the NHS in England, in a press release.
June Raine, chief executive of the MHRA, said her team reviewed two case reports of allergic reactions on Tuesday evening. The two, NHS staff members, are recovering well, the health service said.
“We know from very extensive clinical trials that this was not a feature, that if we need to strengthen our advice now that we have had this experience in vulnerable populations, we immediately get that advice in the field,” said Raine. a panel of legislators.
Pfizer and BioNTech have said they support the MHRA in its investigation.
The British agency had previously warned in its prescribing information that people with allergies to any ingredient in the vaccine should not take it. Patients with a history of severe adverse reactions to a vaccine or severe allergic reactions to any component of the treatment have beenexcludedto participate in the large study conducted by the companies before approval.
“In the pivotal Phase 3 clinical trial, this vaccine was generally well tolerated without any serious safety concerns reported by the independent data monitoring committee,” the companies said in a statement.
More health and Big Pharma coverage of Fortune:
- A depleted workforce with no end in sight: An inside look at the struggling healthcare industry in the United States
- Getting to the COVID-19 finish line: A drama in three acts
- the the science behind the main COVID vaccines will lead to faster manufacturing
- How? ‘Or’ What China’s COVID-19 vaccines could fill the gap leave by Pfizer, Modern, AstraZeneca
- Who receives the first COVID-19 vaccines? Historic UK rollout reveals who has priority
[ad_2]
